Fig. 2

The follow-up information of each patient. The length of each bar represents a patient’s survival time (months) from the date of hCD19 CAR-T cell infusion to the date of death or last follow-up. Among 6 non-responders to hCD19 CAR-T, 3 died of disease progression; 3 received salvage transplantation and achieved remission, of them, 2 relapsed again and 1 died